Vaccinated individuals less likely to develop SARS-CoV-2 anti-nucleocapsid antibodies post ...

Retrieved on: 2022-07-18 21:36:20

Tags for this article:

Click the tags to see associated articles and topics

Vaccinated individuals less likely to develop SARS-CoV-2 anti-nucleocapsid antibodies post .... View article details on hiswai:

Excerpt

1. Following a SARS-CoV-2 (COVID-19) infection, patients who received the Moderna mRNA-1273 vaccine were less likely to develop anti-nucleocapsid ...

Article found on: www.2minutemedicine.com